FDA Drug Application (020251) for ZANTAC 25 by GLAXO GRP LTD

Back to FDA Applications sponsored by GLAXO GRP LTD

Application Number020251
Product Number003
FormTABLET, EFFERVESCENT;ORAL
DosageEQ 25MG BASE
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameZANTAC 25
Active IngredientRANITIDINE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient RANITIDINE HYDROCHLORIDE7


Back to FDA Applications sponsored by GLAXO GRP LTD